Capella Inc., an Auburndale, Mass.-based developer of bifurcated medical stents, has secured $7.9 million of a $23.1 million Series B round, according to a regulatory filing. Backers include PolyTechnos Ventures.
Capella Raising Series B
Capella Inc., an Auburndale, Mass.-based developer of bifurcated medical stents, has secured $7.9 million of a $23.1 million Series B round, according to a regulatory filing. Backers include PolyTechnos Ventures.
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.